NEI Research News

Researchers have shown that ranibizumab eye injections, often in combination with laser treatment, result in better vision than laser treatment alone for diabetes-associated swelling of the retina.

Scientists have shown that through an eye exam, doctors can identify infants who are most likely to benefit from early treatment for a potentially blinding eye condition called retinopathy of prematurity (ROP), resulting in better vision for many children

The National Eye Institute mourns the loss of M. Velma Dobson, Ph.D., a long-time advisor and expert on NEI clinical research studies in infants and children. She passed away on Friday, April 9 from Lou Gehrig’s disease.

NEI support leading to gene therapy clinical trials for people with Leber congenital amaurosis (LCA) consisted of significant efforts by investigators in the intramural laboratories at the NEI.

Scientists have found that laser therapy is equivalent to two different dosages of corticosteroid medications for treating vision loss from the blockage of small veins in the back of the eye, a condition known as branch retinal vein occlusion (BRVO).

Eye injections of corticosteroid medication may improve patients’ vision

Three young adults who received gene therapy for a blinding eye condition remained healthy and maintained previous visual gains one year later, according to an August online report in Human Gene Therapy.

Erik Weihenmayer has climbed mountains around the world - the highest peaks, in fact, on every continent. One afternoon a few years ago, however, a climbing wall in a local gym served as the setting of a most memorable journey.

The National Eye Institute (NEI), part of the National Institutes of Health (NIH), announces the release of more than 10 years of data collected during the Age-Related Eye Disease Study (AREDS).

Scientists have found a more effective treatment for a common childhood eye muscle coordination problem called convergence insufficiency (CI).